Gene Therapy
- Identification of a Mutated Fibronectin as a Tumor Antigen Recognized by DR2-Restricted CD4+ T Cells: Implications for Cancer Vaccines Designed to Prevent Metastasis - 03-042
- Direct Reversal of the Suppressive Function of CD4+ Regulatory T Cells: Augmenting the Effectiveness of Immunotherapies for Cancer, Infectious Diseases or Autoimmunity - 05-065
- Reversible Activation of Low-Density Lipoprotein (LDL) Receptor-Related Protein 5 (LRP5) Activates Wnt Signaling and Promotes Osteoblastogenesis - 05-076
- New Polymerase III-Specific Promoter to Drive RNA Expression for RNAi Applications - 06-017
- Retargeting of Helper-Dependent Adenovirus by Modification of the Fiber with Metabolic Biotinylation - 07-086
- Controlling the Differentiation of Embryonic Stem Cells: The Use of Caspase Inhibitors and Cleavage Resistant Forms of Nanog to Maintain Stem Cell Pluripotency. - 08-058
- Patent Portfolio Entitled "Nucleic Acid Transporter Systems and Methods of Use" - 92-01
- A Novel Method in Cancer Therapy: Expression Vector for Human C/EBP Alpha Gene - 93-16